Browse Pet Safety Reports
18,045 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 18,045 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product, widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 18,045 FDA veterinary adverse event reports for Horse.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Apr 5, 2024 | Horse | Quarter Horse, Horse (unkno... | Clodronate Disodium | Twitching; Lying down; Increased heart rate; Head down | Recovered/Normal |
| Apr 5, 2024 | Horse | Horse (unknown) | Ceftiofur Crystalline Free Acid | Injection site swelling; Decreased appetite; Colitis; Endotoxaemia; Septicaem... | Euthanized |
| Apr 5, 2024 | Horse | Quarter Horse | Ceftiofur Crystalline Free Acid | Collapse NOS (see also Cardio-vascular and Neurological disorders); Moribund;... | Euthanized |
| Apr 5, 2024 | Horse | Quarter Horse | Pergolide Mesylate | Abnormal adrenocorticotropic hormone (ACTH) stimulation test; Aggression; Pol... | Recovered/Normal |
| Apr 5, 2024 | Horse | Horse (unknown) | Flunixin Meglumine Injectable | Injection site swelling; Decreased appetite; Colitis; Endotoxaemia; Septicaem... | Euthanized |
| Apr 4, 2024 | Horse | Quarter Horse | Pentosan Polysulfate Sodium | Injection site swelling | Recovered/Normal |
| Apr 4, 2024 | Horse | Thoroughbred | Firocoxib | Enlarged lymph node (localised); Seroma; Alopecia local; Lethargy (see also C... | Outcome Unknown |
| Apr 4, 2024 | Horse | Horse (unknown) | Ketamine Hydrochloride | Lack of efficacy - NOS | Outcome Unknown |
| Apr 4, 2024 | Horse | Arab | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Apr 3, 2024 | Horse | Warmblood - Dutch, Welsh Po... | Pentosan Polysulfate Sodium | Injection site pain; Injection site swelling | Recovered/Normal |
| Apr 3, 2024 | Horse | Quarter Horse | Deslorelin Acetate | Increased sweating; Rolling; Not eating; Elevated temperature | Recovered/Normal |
| Apr 2, 2024 | Horse | Quarter Horse | Praziquantel;Moxidectin | Death; Lethargy (see also Central nervous system depression in Neurological);... | Died |
| Apr 2, 2024 | Horse | Unknown | Sodium Hyaluronate | Application site swelling; No sign | Outcome Unknown |
| Apr 2, 2024 | Horse | Horse (other) | Pentosan Polysulfate Sodium | Not eating; Fever; Tongue disorder NOS; Behavioural disorder NOS; Lethargy (s... | Recovered/Normal |
| Apr 2, 2024 | Horse | Unknown | Sodium Hyaluronate | Application site infection; No sign | Outcome Unknown |
| Apr 2, 2024 | Horse | Thoroughbred | Pentosan Polysulfate Sodium | Fever; Swollen limb; Lameness; Warm feeling to the touch; Other abnormal test... | Outcome Unknown |
| Apr 1, 2024 | Horse | Thoroughbred | Moxidectin | Lack of efficacy (endoparasite) - strongylids | Outcome Unknown |
| Apr 1, 2024 | Horse | Pony (unspecified) | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Apr 1, 2024 | Horse | Horse (unknown) | Pergolide Mesylate | General hair loss | Outcome Unknown |
| Apr 1, 2024 | Horse | Horse (unknown) | Hyaluronate Sodium | Lack of efficacy - NOS | Outcome Unknown |
| Mar 29, 2024 | Horse | Horse (other) | Ceftiofur Crystalline Free Acid | Collapse NOS (see also Cardio-vascular and Neurological disorders); Hives (se... | Recovered/Normal |
| Mar 29, 2024 | Horse | Horse (unknown) | Butorphanol Tartrate | Lack of efficacy - NOS | Outcome Unknown |
| Mar 29, 2024 | Horse | Warmblood (unspecified) | Flunixin Meglumine | Shaking; Difficulty standing; Ataxia; Anaphylaxis | Recovered/Normal |
| Mar 29, 2024 | Horse | Paint | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Mar 29, 2024 | Horse | Horse (unknown) | Pergolide Mesylate | Lack of efficacy - NOS; Leucopenia NOS; Lymphopenia; High adrenocorticotropic... | Outcome Unknown |
| Mar 29, 2024 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Mar 28, 2024 | Horse | Quarter Horse | Ivermectin; Praziquantel | Cough; Tachypnoea; Tongue protrusion; Application site swelling; Mouth irrita... | Recovered/Normal |
| Mar 28, 2024 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Mar 28, 2024 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Mar 28, 2024 | Horse | Horse (unknown) | Detomidine Hydrochloride | Lack of efficacy - NOS | Recovered/Normal |
| Mar 27, 2024 | Horse | Quarter Horse | Ceftiofur Crystalline Free Acid | Colic | Recovered/Normal |
| Mar 27, 2024 | Horse | Mustang | Omeprazole | Anorexia; Lethargy (see also Central nervous system depression in Neurologica... | Recovered/Normal |
| Mar 26, 2024 | Horse | Arab | Omeprazole | INEFFECTIVE, GASTRIC ULCER(S); Partial lack of efficacy | Outcome Unknown |
| Mar 26, 2024 | Horse | Friesian | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Mar 26, 2024 | Horse | Quarter Horse | Flunixin Meglumine Injectable | Injection site swelling | Recovered/Normal |
| Mar 26, 2024 | Horse | Unknown | Sodium Hyaluronate | Injection site infection; No sign | Outcome Unknown |
| Mar 26, 2024 | Horse | Quarter Horse | Flunixin Meglumine Injectable | Injection site swelling; Injection site pain | Recovered/Normal |
| Mar 25, 2024 | Horse | Pony of the Americas | Firocoxib | Abscess NOS | Outcome Unknown |
| Mar 25, 2024 | Horse | Tennessee Walking Horse | Pergolide Mesylate | Ataxia; Head down | Recovered/Normal |
| Mar 25, 2024 | Horse | Connemara Pony | Polysulfated Glycosaminoglycan | Partial anorexia; Itching | Outcome Unknown |
| Mar 23, 2024 | Horse | Quarter Horse | Polysulfated Glycosaminoglycan | Tremor of limb; Tremor | Recovered/Normal |
| Mar 22, 2024 | Horse | Thoroughbred | Omeprazole | Lack of efficacy - NOS | Recovered/Normal |
| Mar 22, 2024 | Horse | Horse (unknown) | Firocoxib | Injection site swelling; Injection site abscess; Lameness | Ongoing |
| Mar 21, 2024 | Horse | Horse (unknown) | Omeprazole | Colic; INEFFECTIVE, GASTRIC ULCER(S) | Recovered/Normal |
| Mar 21, 2024 | Horse | Quarter Horse | Clodronate Disodium | Colic; Flehmen response; Pawing | Recovered/Normal |
| Mar 20, 2024 | Horse | Thoroughbred | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Mar 20, 2024 | Horse | Horse (unknown) | Ciclesonide | Behavioural disorder NOS; Device use issues NOS | Outcome Unknown |
| Mar 20, 2024 | Horse | Warmblood (unspecified) | Flunixin Meglumine Injectable | Colic; Digestive tract hypomotility | Recovered/Normal |
| Mar 20, 2024 | Horse | Standardbred (unspecified) | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Mar 20, 2024 | Horse | Warmblood (unspecified) | Moxidectin | Colic; Digestive tract hypomotility | Recovered/Normal |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe, difficulty breathing, seizures, collapse, or severe swelling, seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.